San Francisco Sentry Investment Group CA boosted its position in shares of Humana Inc (NYSE:HUM) by 46.9% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 598 shares of the insurance provider’s stock after purchasing an additional 191 shares during the period. San Francisco Sentry Investment Group CA’s holdings in Humana were worth $203,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in HUM. Stratos Wealth Partners LTD. acquired a new stake in Humana during the 3rd quarter valued at $108,000. Sun Life Financial INC grew its holdings in Humana by 120.7% during the 2nd quarter. Sun Life Financial INC now owns 373 shares of the insurance provider’s stock valued at $111,000 after purchasing an additional 204 shares in the last quarter. Migdal Insurance & Financial Holdings Ltd. grew its holdings in Humana by 2,984.6% during the 2nd quarter. Migdal Insurance & Financial Holdings Ltd. now owns 401 shares of the insurance provider’s stock worth $119,000 after acquiring an additional 388 shares in the last quarter. Smithfield Trust Co. grew its holdings in Humana by 531.2% during the 3rd quarter. Smithfield Trust Co. now owns 486 shares of the insurance provider’s stock worth $165,000 after acquiring an additional 409 shares in the last quarter. Finally, Girard Partners LTD. acquired a new position in Humana during the 3rd quarter worth $169,000. 93.05% of the stock is owned by institutional investors and hedge funds.

Several research analysts have weighed in on HUM shares. Argus raised their price objective on shares of Humana to $375.00 and gave the stock a “buy” rating in a report on Tuesday, September 4th. Piper Jaffray Companies reissued a “buy” rating and set a $355.00 price objective on shares of Humana in a report on Thursday, August 2nd. Bank of America raised their price objective on shares of Humana from $338.00 to $375.00 and gave the stock a “buy” rating in a report on Thursday, August 2nd. Jefferies Financial Group raised their price objective on shares of Humana from $356.00 to $372.00 and gave the stock a “buy” rating in a report on Thursday, August 2nd. Finally, Zacks Investment Research raised shares of Humana from a “hold” rating to a “buy” rating and set a $377.00 price objective for the company in a report on Thursday, October 4th. Seven investment analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the stock. Humana presently has an average rating of “Buy” and an average target price of $352.30.

In other news, CEO Bruce D. Broussard sold 18,000 shares of the firm’s stock in a transaction dated Monday, September 10th. The shares were sold at an average price of $328.66, for a total value of $5,915,880.00. Following the transaction, the chief executive officer now directly owns 71,085 shares in the company, valued at approximately $23,362,796.10. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Roy A. Beveridge sold 4,622 shares of Humana stock in a transaction dated Thursday, November 8th. The shares were sold at an average price of $341.06, for a total transaction of $1,576,379.32. Following the completion of the sale, the insider now owns 10,621 shares in the company, valued at $3,622,398.26. The disclosure for this sale can be found here. Company insiders own 0.60% of the company’s stock.

Humana stock opened at $310.40 on Tuesday. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.68 and a current ratio of 1.68. Humana Inc has a 1 year low of $231.90 and a 1 year high of $355.88. The stock has a market capitalization of $43.86 billion, a PE ratio of 26.51, a price-to-earnings-growth ratio of 1.52 and a beta of 1.03.

Humana (NYSE:HUM) last posted its quarterly earnings results on Wednesday, November 7th. The insurance provider reported $4.58 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $4.29 by $0.29. Humana had a net margin of 2.70% and a return on equity of 19.10%. The company had revenue of $14.21 billion for the quarter, compared to the consensus estimate of $13.97 billion. During the same period last year, the firm posted $3.39 EPS. On average, research analysts expect that Humana Inc will post 14.43 earnings per share for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, January 25th. Stockholders of record on Monday, December 31st will be given a $0.50 dividend. The ex-dividend date is Friday, December 28th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.64%. Humana’s payout ratio is currently 17.08%.

WARNING: This report was first posted by Daily Political and is the property of of Daily Political. If you are reading this report on another website, it was stolen and reposted in violation of United States and international copyright & trademark law. The original version of this report can be viewed at https://www.dailypolitical.com/2018/11/20/san-francisco-sentry-investment-group-ca-acquires-191-shares-of-humana-inc-hum.html.

About Humana

Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. The company operates through four segments: Retail; Group and Specialty; Healthcare Services; and Individual Commercial. The Retail segment offers Medicare and supplemental benefit plans to individuals or through group accounts.

Recommended Story: Do Tariffs Work?

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc (NYSE:HUM).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.